# Combined Therapy of Posterior Subtenon Triamcinolone Acetonide and Intravitreal Bevacizumab for Macular Edema Secondary to Branch Retinal Vein Occlusion

> **NCT01614509** · NA · COMPLETED · sponsor: **Yeungnam University College of Medicine** · enrollment: 45 (actual)

## Conditions studied

- Branch Retinal Vein Occlusion

## Interventions

- **PROCEDURE:** intravitreal bevacizumab monotherapy
- **PROCEDURE:** combined therapy of posterior subtenon triamcinolone acetonide and intravitreal bevacizumab injection

## Key facts

- **NCT ID:** NCT01614509
- **Lead sponsor:** Yeungnam University College of Medicine
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-01
- **Primary completion:** 2012-08
- **Final completion:** 2012-08
- **Target enrollment:** 45 (ACTUAL)
- **Last updated:** 2012-12-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01614509

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01614509, "Combined Therapy of Posterior Subtenon Triamcinolone Acetonide and Intravitreal Bevacizumab for Macular Edema Secondary to Branch Retinal Vein Occlusion". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT01614509. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*